The Investor Relations website contains information about Xenon Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Is XENE a good stock to buy?
Who is the CEO of XENE?
What do xenon pharmaceuticals do?
How many employees does Xenon Pharmaceuticals have?
(Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Stifel 2024 Virtual CNS Days event. Company ...
Find the latest institutional holdings data for Xenon Pharmaceuticals Inc. Common Shares (XENE) including shareholders, ownership summaries, ...
The Investor Relations website contains information about Xenon Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.
6 days ago · For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 investors@xenon-pharma.com. For Media: Jodi Regts Xenon Corporate ...
(US:XENE) has 379 institutional owners and shareholders ... Investor Shares, Capital International Investors, and Commodore Capital Lp . ... relation to this ...
Attn: Investor Relations 200 – 3650 Gilmore Way Burnaby, BC V5G 4W8 Canada (604) 484-3300. You may also access the documents incorporated by reference in ...
Find annual and quearterly earnings data for Xenon Pharmaceuticals Inc. Common Shares (XENE) including earnings per share, earnings forecasts at Nasdaq.com.
Xenon Pharmaceuticals Inc. (XENE) Stock Price, News, Quote & History
finance.yahoo.com › quote › XENE
Find the latest Xenon Pharmaceuticals Inc. (XENE) stock quote, history, news and other vital information to help you with your stock trading and investing.
For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 investors@xenon-pharma.com. For Media: Jodi Regts Xenon Corporate Affairs (604) ...